Manufacturers

Alfa Chemistry is a global Contract Research Organization (CRO) specializing in organic chemistry, material chemistry, and medicinal chemistry, and is ISO 9001:2015 certified. The company provides a wide range of building blocks, research chemicals, reagents, catalysts, and reference materials for diverse scientific applications. In addition, Alfa Chemistry is a leading integrated provider of peptide R&D, production, and sales. It offers a broad portfolio of high-quality peptide products, including hydrolyzed protein peptides, fish collagen peptides, marine fish oligopeptides, oyster peptides, sea cucumber peptides, as well as plant-derived peptides such as pea, soy, and walnut peptides. Alfa Chemistry also delivers customized synthetic peptide services with flexible options in labeling, scale, purity, and turnaround time to meet various research needs. Each custom peptide undergoes strict quality control, including verification by mass spectrometry (MS) and high-performance liquid chromatography (HPLC) throughout the purification and QC processes, ensuring consistent quality and reliability.

Creative Diagnostics' SpeX® Earthworm Microsome model is a crucial for studying drug metabolism and the environmental fate of pharmaceuticals within soil biocommunity systems. This model assists researchers in evaluating the environmental risks and ecotoxicity of pharmaceuticals. Additionally, the metabolic mechanisms of earthworms and mammalian intestines are highly similar (both are rich in CYP450 enzymes and transferases), making this novel product an ideal complementary model for mammalian drug metabolism research. It effectively simulates the first-pass metabolism of orally administered drugs and provides a vital tool for bioavailability studies. Most significantly, as a unique non-mammalian model, earthworm microsomes open new avenues for exploring novel metabolic pathways and drive innovation in drug metabolism research.

Creative Diagnostics' research team studies multiple influenza A strains, including H9N2, H1N1, and H3N2. The company offers clients a portfolio of customized and standardized preclinical services utilizing mouse infection models to evaluate pathogenic mechanisms, humoral immune responses, and protective efficacy induced by wild-type influenza A viruses or influenza vaccines. The mouse models include H9N2 Avian Influenza Mouse Model, H1N1 Strain Mouse Model, Pdm H1N1 Strain Mouse Model, and H3N2 Strain Mouse Model.